Mechanisms and Clinical Recognition and Management of Heart Failure in Infants and Children
Author:
Marín-García José
Reference133 articles.
1. Ross RD, Bollinger RO, Pinsky WW (1992) Grading the severity of congestive heart failure in infants. Pediatr Cardiol 13:72–75
2. Reithmann C, Reber D, Kozlik-Feldmann R et al (1997) A post-receptor defect of adenylyl cyclase in severely failing myocardium from children with congenital heart disease. Eur J Pharmacol 330:79–86
3. Mir TS, Marohn S, Laer S, Eiselt M, Grollmus O, Weil J (2002) Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 110:e76
4. Tissieres P, Aggoun Y, Da Cruz E et al (2006) Comparison of classifications for heart failure in children undergoing valvular surgery. J Pediatr 149:210–215
5. Mangat J, Carter C, Riley G, Foo Y, Burch M (2009) The clinical utility of brain natriuretic peptide in paediatric left ventricular failure. Eur J Heart Fail 11:48–52